These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26292509)

  • 1. [ASSESSMENT OF INDICATORS FOR INTERFERON SYSTEM IN PATIENTS WITH COMMON FORMS OF PULMONARY TUBERCULOSIS RECEIVING COMPLEX THERAPY WITH CYCLOFERON].
    Budritskii AM; Pravada NS
    Eksp Klin Farmakol; 2015; 78(6):15-8. PubMed ID: 26292509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Meglumine acridonacetate and complex therapy of patients with newly identified advanced pulmonary tuberculosis].
    Pravada NS; Budritskiĭ AM; Sukhanov DS
    Antibiot Khimioter; 2014; 59(5-6):15-9. PubMed ID: 25552039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of immunomodulating therapy of pulmonary tuberculosis with cycloferon].
    Kolomiets VM; Rubleva NV
    Klin Med (Mosk); 2013; 91(5):56-9. PubMed ID: 24159790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of safety and pharmacotherapeutic efficacy of cycloferon in treatment of Astrakhan rickettsial fever].
    sherysheva IuV; Galimzianov KhM; Kovalenko AL
    Antibiot Khimioter; 2012; 57(1-2):26-31. PubMed ID: 22741199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cycloferon in the complex therapy of patients with widespread forms of pulmonary tuberculosis].
    Demidik SN; Sukhanov DS
    Eksp Klin Farmakol; 2012; 75(5):17-20. PubMed ID: 22834123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between the endogenous interferon IFN-gamma level and risk of hepatotoxic liver damage in tuberculosis patients].
    Sukhanov DS; Okovityĭ SV; Demidik SN; Ivanov AK; Romantsov MG
    Eksp Klin Farmakol; 2012; 75(6):40-3. PubMed ID: 22891441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dose-dependent interferon-induction activity and pharmacokinetics of cycloferon in healthy humans].
    Sukhanov DS; Romantsov MG; Smagina AN; Kovalenko AL; Lokteva OM
    Eksp Klin Farmakol; 2012; 75(1):23-6. PubMed ID: 22442959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Type 1 and type 2 interferon inductor (cycloferon) in therapy of children with pyelonephritis associated with herpes viruses].
    Orekhova SB; Botvin'ev OK; Romantsov MG
    Antibiot Khimioter; 2009; 54(5-6):48-53. PubMed ID: 20052918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined cycloferon treatment of tuberculosis in patients infected with HIV].
    Ivanov AK; Sologub TV; Panteleev AM; Sukhanov DS; Romantsov MG; Kovalenko AL
    Eksp Klin Farmakol; 2010 Jul; 73(7):32-5. PubMed ID: 20821978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An experimental study of the efficiency of cycloferon in the complex chemotherapy of generalized drug-resistant tuberculosis].
    Sukhanov DS; Vinogradova TI; Demidik SN; El'kin AV; Zabolotnykh NV; Vasil'eva SN; Vitovskaia ML; Romantsov MG
    Eksp Klin Farmakol; 2012; 75(9):32-6. PubMed ID: 23156086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of therapy with interferon inducer on the parameters of quality of life in patients with pulmonary tuberculosis].
    Demidik SN; Romantsov MG; Smagina AN; Vol'f SB
    Lik Sprava; 2013 Mar; (2):93-8. PubMed ID: 24605618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)].
    Sologub TV; Shul'diakov AA; Romantsov MG; Zhekalov AN; Petlenko SV; Erofeeva MK; Maksakova VL; Isakov VA; Zarubaev VV; Gatsan VV; Kovalenko AL
    Antibiot Khimioter; 2009; 54(7-8):30-2, 34-6. PubMed ID: 20201401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cycloferon therapy of acute and chronic virus hepatitis C].
    Malyĭ VP; Pen'kov DV; Chiriukina OI
    Antibiot Khimioter; 2013; 58(9-10):34-40. PubMed ID: 24738241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunomodulator Intensification of Etioropic Therapy in Patients with Advanced Pulmonary Tuberculosis].
    Kolomiets VM; Abramov AV; Rachina NV; Rubleva NV
    Antibiot Khimioter; 2015; 60(7-8):18-22. PubMed ID: 26863738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic efficacy of various formulations of cycloferon in the treatment of infectious mononucleosis in children].
    Kurmaeva DIu; Baranova IP
    Antibiot Khimioter; 2011; 56(9-10):33-6. PubMed ID: 22586902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The use of cycloferon in the combined treatment of tuberculosis patients infected with HIV and viral hepatitis].
    Ivanov AK; Panteleev AM; Sukhanov DS; Sologub TV; Romanov MG
    Klin Med (Mosk); 2010; 88(5):49-52. PubMed ID: 21089459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of cycloferon in complex therapy of infectious mononucleosis in pediatrics].
    Kasymova EB; Bashkina OA; Galimzianov KhM
    Antibiot Khimioter; 2011; 56(9-10):37-40. PubMed ID: 22586903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenetic therapy of tuberculosis of respiratory organs during sanatorium-and-spa treatment].
    Sukhanov DS; Ivanov AK; Kovalenko AL; Dziuba EG; Andreeva MN; Romantsov MG
    Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (6):34-7. PubMed ID: 20017380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of cycloferon on tonsils microflora in often ill children].
    lialikov SA; Bedin PG; Ermak SIu; Ianovich RV
    Eksp Klin Farmakol; 2013; 76(3):31-4. PubMed ID: 23767101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of side effects and estimation of cycloferon efficacy in treatment of children with frequent and prolonged diseases].
    Lialikov SA; Romantsov MG; Bedin PG; Ermak SIu
    Antibiot Khimioter; 2012; 57(11-12):26-32. PubMed ID: 23700934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.